Watera (ALWTR) Fair Value & Analysis
Industrials · FR · Market cap €22.4M
Fair value as of: Jun 24, 2026
Analysis
Watera (ALWTR) currently trades at €1.12, while our model-based Fair Value estimate is €1.94 — implying the stock looks roughly 74.0% undervalued today. We read business quality at 92/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Watera provides water treatment solutions with the use of renewable energy in France. The company offers OSMOSUN that provides sea and brackish water, reverse osmosis desalination units; OSMO-WATT, a containerized solar powered solution for seawater and brackish water desalination; OSMOSUN TAPS, an integrated drinking water production solution for remote areas; and OSMOSUN NOMAD, a water treatment unit. The company also operates in the low-carbon water market and develops and sells patented, clean, and sustainable solutions for solar-powered, battery-free seawater and brackish water desalination. It serves remote communities, municipal, emergency situations, agriculture, hotels, base camps, and industrial activities, and mining industries. The company was formerly known as Osmosun S.A. and changed its name to Watera in March 2026. Watera was incorporated in 2014 and is based in Gellainville, France.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Watera (ALWTR) undervalued?
What is the fair value of ALWTR?
What is the quality score of ALWTR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.